What is the appropriate management for a preterm infant presenting with nasal flaring and grunting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Preterm Infant with Nasal Flaring and Grunting

Immediately initiate nasal CPAP at 5-8 cm H₂O pressure as first-line respiratory support, with selective surfactant administration only if the infant subsequently requires mechanical ventilation. 1

Initial Respiratory Support Strategy

  • Start CPAP immediately using nasal prongs, nasopharyngeal tube, or mask at 5-8 cm H₂O pressure rather than routine intubation 1
  • Use blended oxygen guided by pulse oximetry, avoiding both hyperoxemia and hypoxemia 1
  • For preterm infants <32 weeks' gestation, begin with 21-30% oxygen and titrate upward as needed rather than starting with 100% oxygen 1
  • This approach has Level 1 evidence (Strong Recommendation) from the American Academy of Pediatrics as an alternative to routine intubation with prophylactic surfactant 2, 1

Why CPAP First Works

  • Early CPAP with selective surfactant results in lower rates of bronchopulmonary dysplasia and death compared to prophylactic surfactant therapy 1
  • Approximately 50% of preterm infants managed with early CPAP will never require surfactant or mechanical ventilation 1
  • The SUPPORT trial (N=1,310) demonstrated that CPAP started immediately after birth resulted in less respiratory morbidity at 18-22 months corrected age compared to routine intubation 2, 1
  • Mean duration of ventilation is shorter with initial CPAP (3 days vs 4 days with immediate intubation) 2

When to Escalate to Surfactant

Administer surfactant if the infant requires mechanical ventilation despite CPAP, particularly for preterm infants <30 weeks' gestation with severe RDS 2, 1

Use the INSURE Strategy:

  • Intubate the infant
  • Administer Surfactant (animal-derived preferred over synthetic)
  • Rapidly Extubate back to CPAP 2, 1, 3

This approach significantly reduces the need for prolonged mechanical ventilation (RR 0.67; 95% CI 0.57-0.79) 2

Timing Matters:

  • If surfactant is needed, give it as early rescue within 1-2 hours rather than delayed treatment 2
  • Early rescue surfactant decreases mortality (RR 0.84), air leak (RR 0.61), and chronic lung disease (RR 0.69) compared to delayed administration 2

Critical Pitfalls to Avoid

  • Do not routinely intubate without first attempting CPAP - this increases complications without improving outcomes 1
  • Be aware that CPAP carries a higher pneumothorax risk (9% vs 3% with intubation), but results in better long-term respiratory outcomes 2, 1
  • Avoid excessive CPAP pressures (8-12 cm H₂O) as these may reduce pulmonary blood flow and increase pneumothorax risk 1
  • Do not withhold surfactant if mechanical ventilation becomes necessary - these infants have true surfactant deficiency requiring replacement therapy 4
  • Many extremely preterm infants, even those as immature as 24-25 weeks' gestational age, can be successfully managed with CPAP alone 1

Monitoring Requirements

  • Continuous pulse oximetry (preferably preductal on right hand/wrist) 4
  • Continuous respiratory rate, heart rate, and blood pressure monitoring 4
  • Serial assessment for increased work of breathing, worsening retractions, or apnea indicating CPAP failure 5
  • Blood gas measurement if clinical deterioration occurs 5

References

Guideline

Management of Preterm Infant with Respiratory Distress

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Extubation Criteria for Extreme Preterm Neonates

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Respiratory Distress in Newborns of Diabetic Mothers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Newborn Respiratory Distress.

American family physician, 2015

Related Questions

What is the initial management for a newborn with grunting and respiratory distress?
What is the next step in management for a 33-week preterm neonate with respiratory distress, grunting, and chest retraction?
What is the initial management for a newborn with grunting and respiratory distress?
What is the next step in managing a full-term baby delivered by cesarean section (C-section) with respiratory distress without desaturation and fluid in pulmonary fissures on chest X-ray?
What is the likely diagnosis for a 33-week premature baby, delivered by cesarean section (CS) to a diabetic mother, presenting with grunting, respiratory distress, and cyanosis?
Should pembrolizumab (programmed death receptor-1 inhibitor) be continued as part of chemoradiation therapy (CRT) in a patient with buccal mucosa carcinoma who showed disease progression on PET (positron emission tomography) CT after receiving neoadjuvant pembrolizumab with DCF (docetaxel, cisplatin, and 5-fluorouracil) and has undergone surgery?
What are alternative treatment options for a patient with melasma when tranexamic acid (TXA) solution is not readily available?
What is the recommended intraoperative anesthetic management for a patient undergoing anterior mediastinal mass excision?
Can tranexamic acid (TXA) injections be used to compound a 10% TXA solution for a patient with melasma?
What are the treatment options for a patient who develops a knot or lump after an injection, particularly if they have a history of bleeding disorders or are taking anticoagulant medications?
Can I experience a hangover-like effect from Ativan (lorazepam) after only 3 hours of sleep, given my sleep-deprived state and recent prescription of metronidazole for an infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.